SAN DIEGO, January 10, 2022 (GLOBE NEWSWIRE) – Johnson Fistel, LLP is investigating potential claims on behalf of Silverback Therapeutics, Inc. (“Silverback” or the “Company”) (NASDAQ: SBTX) against certain of its officers and directors.

Earlier this year, a class action lawsuit was filed against Silverback. According to the lawsuit, the IPO documents presented and the defendants throughout the claim period made false and / or misleading statements and / or failed to disclose that: (1) Silverback SBT6050’s primary product candidate (a TLR8 linker-load agonist directed monoclonal antibody that targets tumors, such as breast, stomach and non-small cell lung cancers) was less effective than what the Company had represented to investors; (2) as a result, the Company overestimated the commercial and / or clinical outlook for SBT6050; and (3) accordingly, the IPO documents and the defendants’ public statements throughout the Class Period were materially false and / or misleading and did not indicate the information required to be included therein. When the real details entered the market, the lawsuit claims that investors have suffered damage.

If you are a current long-term shareholder of Silverback holding shares before January 2021, you may have standing to protect Silverback (and its shareholders) from the alleged harm caused by the officers and directors of the Company by making them personally liable. You may also be able to help reform the corporate governance of the Company to avoid future wrongdoing. There is no cost or obligation for you.

[Click here to join this action]

If you would like to know more about the investigation, please contact Senior Analyst Jim Baker ([email protected]) at 619-814-4471. If you are sending an email, please include a phone number.

About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in class actions between shareholders and derivatives. For more information about the firm and its lawyers, please visit http://www.johnsonfistel.com. Lawyer advertising. Past results do not guarantee future results.

[Click here to join this action]